Clinical Trials Logo

Clinical Trial Summary

Cardiac output monitoring is a key component for the diagnosis and management of critically ill patients. The two less invasive methods commonly used in intensive care are transthoracic echocardiography and transpulmonary thermodilution. The objective of this study is to compare accuracy and trending ability of CO measurement by TPTD and TTE in critically ill patients with sinus rhythm.


Clinical Trial Description

TTE is an easy noninvasive device now recommended as the first evaluation of the patient in circulatory failure but it present some limits due to poor echogenicity of patients, operator-dependent variability and cannot provide continuous hemodynamic data. TPTD is an invasive technique for CO monitoring recommended especially in shock not responsive to initial therapy. Few studies have evaluated the level of agreement of each method (TTE and TPTD) with the reference method (pulmonary artery catheter) but they have never been compared between them with strong statistical analysis in particular trending ability. It could be interesting to determine the level of concordance of these two methods of CO monitoring and trend ability by TPTD relative to TTE. The investigators hypothesize that CO-TPTD are concordant with those performed by TTE. Mechanically ventilated patients requiring hemodynamic assessment will be included. CO-TPTD will be measured via intermittent thermodilution. Blindly, a second investigator will use standard-view TTE to estimate CO-TTE as the product of stroke volume and the heart rate obtained during the measurement the blood flow velocity (using a Doppler technique) at the left ventricular outflow tract. A second measurement will be done with the two devices after a fluid challenge when patient requires it to compare trending ability. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04637126
Study type Observational
Source University Hospital, Toulouse
Contact
Status Completed
Phase
Start date March 6, 2020
Completion date February 10, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT04637230 - Prevention of Stroke and Sudden Cardiac Death by Recording of 1-Channel Electrocardiograms
Not yet recruiting NCT04696120 - Effects of APIXaban on BRAIN Protection in Patients With Sinus Rhythm and Heart Failure: APIXBRAIN-HF Trial Phase 2
Recruiting NCT04917653 - Portable Measurement Methods Combined With Artificial Intelligence in Detection of Atrial Fibrillation
Recruiting NCT00970034 - Gene Expression Profiles in Patients With Permanent Atrial Fibrillation (AF) Versus Sinus Rhythm (SR) N/A